Previous 10 | Next 10 |
Biomerica (NASDAQ: BMRA ) -28% . More news on: Biomerica, Inc., Waitr Holdings Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more ...
3 Penny Stocks Pushing Higher On Thursday Why do people invest in penny stocks ? A history of big breakouts and quick gains have been a major source of interest. Just this week we witnessed the true potential of penny stocks. Case in point, Blue Apron ( APRN-Free Report ) and Biomerica Inc....
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that it will report 2019 fourth quarter and full year financial results after market close on Thursday, March 26, 2...
NovaBay Pharmaceuticals (NYSEMKT: NBY ) has launched NovaWipes, a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova, on Amazon.com. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Dry wipes are specifically designed for applying Avenova ® to treat dry eye and blepharitis NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the launch of NovaWipes , a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova ® , on A...
The market is vast with many different options for investors to put money into. You can trade anything from penny stocks to large-cap stocks. When it comes to penny stocks, these are considered to be any equity that trades below $5. The cheap stocks can bring investors large amounts of profits...
NovaBay Pharmaceuticals (NYSEMKT: NBY ) is up 21% premarket after the launch of NovaSight, a proprietary daily vitamin and mineral supplement specially formulated to support ocular health, on Amazon.com. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks...
NovaSight complements Avenova ® Direct for comprehensive internal and external eye health NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of NovaSight ™, a proprietary daily vitamin and mineral supplement specially formulated to support o...
NovaBay Pharmaceuticals, Inc. (NBY) Q3 2019 Results Conference Call November 07, 2019 04:30 PM ET Company Participants Jody Cain - Investor Relations Justin Hall - President and Chief Executive Officer Jason Raleigh - Chief Financial Officer Conference Call Participants Jef...
NovaBay (NYSEMKT: NBY ): Q3 GAAP EPS of -$0.02 beats by $0.06 . More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
NovaBay Pharmaceuticals Inc. Company Name:
NBY Stock Symbol:
NYSE Market:
NovaBay Pharmaceuticals Inc. Website:
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Ea...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova ® -branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales were 17% higher compared with Prime Day 2023 and were up 40% over ...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants f...